GlassScriptPhysician profile
David William Sihau
NPI 1902864051
$30,678.56
in general payments reported to CMS, 2019-2025
43 companies · $1,940 in 2025
The $1,940 reported for 2025 was more than what 83% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $830 · 2021: $380 · 2022: $159 · 2023: $700 · 2024: $1,503 · 2025: $1,940.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,963 · Education: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,963.03 |
| Education | $179.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $23,877.18 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $1,019.08 | 2019-2025 | |
| Amgen INC. | $817.36 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $792.80 | 2019-2025 | Farxiga, Brilinta |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $753.39 | 2019-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $529.59 | 2019-2022 | |
| Novo Nordisk INC | $234.33 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Boston Scientific Corporation | $207.51 | 2019-2024 | Bodyguardian, Watchman Access System |
| Bayer Healthcare Pharmaceuticals INC. | $207.09 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $190.02 | 2021-2025 | Verquvo, Capvaxive |
| E.R. Squibb & Sons, L.L.C. | $179.51 | 2019-2025 | Camzyos, Eliquis |
| Edwards Lifesciences Corporation | $165.29 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Regeneron Healthcare Solutions, INC. | $163.71 | 2019 | |
| Pfizer INC. | $140.48 | 2021-2025 | |
| Abbott Laboratories | $128.67 | 2024-2025 | Cardiomems, Aveir, Thoratec Heartmate 3 Lvas Implant Kit |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sihau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.